#Oxford #Brainomix #AI Imaging #Healthtech Awards #England

Brainomix Celebrated for Innovation in AI Imaging Technology

Brainomix, a pioneering force in the field of artificial intelligence imaging solutions, has recently garnered notable recognition for its groundbreaking contributions to healthcare. The company was awarded the prestigious LSX European Lifestars Award for Healthtech Company of the Year, alongside the title of Most Transformative Healthtech Company of the Year by OBN.

These accolades reflect Brainomix's remarkable achievements over the past year, a testament to both its technological advancements and the tangible impact of its innovations on patient care. With nominations from numerous esteemed healthtech innovators globally, these awards highlight the company’s strides in the realm of medical technology.

Significant Achievements in 2024

In less than a year, Brainomix has made substantial progress, gaining endorsement from the National Institute for Health Care Excellence (NICE) and securing multiple FDA clearances for its products, especially in the areas of stroke and lung fibrosis. This expansion not only represents a significant milestone for the company but also marks its entry into the competitive US market.

According to Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix, "We are honored to be recognized by LSX and OBN for these top awards, which reflect the transformative impact our technology is having on patient care globally. We remain committed to delivering cutting-edge AI solutions that will facilitate faster diagnosis and expand access to life-saving treatments for stroke and lung fibrosis patients."

The company is particularly proud of the real-world outcomes demonstrated by its flagship product, Brainomix 360 Stroke, which was the focal point of the largest evaluation of AI imaging technology in stroke management. Presented at the European Stroke Organisation Conference (ESOC), the study revealed a staggering 50% increase in the rate of mechanical thrombectomy procedures enabled by the use of the Brainomix platform.

Enhancing Stroke Treatment Outcomes

Mechanical thrombectomy, a critical intervention in treating severe strokes caused by blockages in major brain blood vessels, has proven to significantly reduce long-term disabilities in affected patients. Not only has Brainomix software improved service delivery in individual hospitals, but it has also enhanced national health systems, as noted in countries like Hungary and Wales where the technology has been implemented across healthcare facilities.

In Hungary, for example, the deployment of Brainomix 360 Stroke across 28 sites resulted in over a 50% increase in thrombectomy rates. Prof. István Szikora from the National Institute of Mental Health, Neurology and Neurosurgery (OMIII) in Budapest stated, “Brainomix 360 Stroke has proved itself an extremely effective asset in improving the efficacy of stroke care in Hungary.”

Similarly, Wales has experienced a 44% increase in thrombectomy procedures, demonstrating the platform's critical role in optimizing stroke care across the country. Dr. Shakeel Ahmad, National Clinical Lead for Stroke in Wales, remarked, “The Brainomix 360 Stroke platform is a game-changer in stroke care, generating critical information from simple brain scans and providing a secure platform for clinicians to share information, images, and analysis, enabling faster and more precise decision-making.”

About Brainomix

Founded as a spin-out from the University of Oxford, Brainomix is committed to revolutionizing the diagnosis and treatment processes in stroke and lung fibrosis. The company has expanded its reach into over 30 countries, continually integrating its pioneering AI solutions into clinical practices.

Backed by prominent healthtech investors, Brainomix has successfully launched award-winning software and imaging biomarkers that are now clinically utilized in hundreds of hospitals worldwide. Their flagship product, Brainomix 360 Stroke, aims to offer the most comprehensive imaging solutions for stroke, ultimately increasing treatment rates and enhancing patient outcomes.

For more insights on their innovations and dedication to advancing healthcare technology, visit Brainomix and follow them on social media platforms including Twitter, LinkedIn, and Facebook.